Pharmaceutical

Protecting your drug products: Strategies for preventin...

Metal contamination in pharmaceutical products is a huge problem. Detection and ...

Risk adjusted net present value: What is the current va...

Idrebormilast is a small molecule commercialized by Pfizer, with a leading Phase...

Risk adjusted net present value: What is the current va...

Rezatapopt is a small molecule commercialized by PMV Pharmaceuticals, with a lea...

Risk adjusted net present value: What is the current va...

Osivelotor is a small molecule commercialized by Pfizer, with a leading Phase II...

Risk adjusted net present value: What is the current va...

Suzetrigine is a small molecule commercialized by Vertex Pharmaceuticals, with a...

Risk adjusted net present value: What is the current va...

Atirmociclib is a small molecule commercialized by Pfizer, with a leading Phase ...

Risk adjusted net present value: What is the current va...

CTX-112 is a gene-modified cell therapy commercialized by CRISPR Therapeutics, w...

Risk adjusted net present value: What is the current va...

Influenza (quadrivalent) vaccine is a mrna vaccine commercialized by Pfizer, wit...

Risk adjusted net present value: What is the current va...

RL-007 is a small molecule commercialized by Atai Life Sciences, with a leading ...

Risk adjusted net present value: What is the current va...

FLT-201 is a gene therapy commercialized by Spur Therapeutics, with a leading Ph...

Risk adjusted net present value: What is the current va...

PF-07264660 is a monoclonal antibody commercialized by Pfizer, with a leading Ph...

Amylyx ventures into metabolic diseases market with $35...

On 17 June, Amylyx acquired the rights to Eiger Biopharmaceutical’s experimental...

Coherus offloads Humira biosimilar Yusimry for $40m

Hong Kong King-Friend Industrial has acquired worldwide rights to Yusimry, and i...